FHIR IG analyticsBy Version
By Authority
By Realm
Start Prev Rows 58600 - 58800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) | Usage # |
|---|---|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-siteDistribution-vs.json | ICH M11 ... | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-siteGeographicscope-vs.json | ICH M11 ... | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-trialBlindSchema-vs.json | ICH M11 ... | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-amendment-scope-enrollment-vs.json | ICH M11 Amendment Scope Enrollment Description Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-amendment-scope-enrollment.json | ICH M11 Amendment Scope Enrollment Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-study-amendment-scope-vs.json | ICH M11 Amendment Scope Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-amendment-scope.json | ICH M11 Amendment Scope Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-yes-no-vs.json | ICH M11 No Yes Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 2 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-yes-no.json | ICH M11 Yes No Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-study-amendment-reason-vs.json | ICH M11 Reason for Amendment Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-amendment-reason.json | ICH M11 Reason for Amendment Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-blinded-roles-vs.json | ICH M11 Trial Blinding Role Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-phase-vs.json | ICH M11 Trial Phase Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-trial-phase.json | ICH M11 Trial Phase Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-interventionModel-vs.json | ICH M11 Intervention Model Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 1 |
| hl7.fhir.uv.clinical-study-protocol | R6 | ValueSet-m11-amendment-details-statement-vs.json | ICH M11 Amendment Details Statement Value Set Terminology | trial-use | 0 | brr | 2026-06 | uv | hl7 | ncit | 2 |
| hl7.fhir.uv.ebm | R6 | ValueSet-ich-m11-amendment-details-statement.json | ICH M11 Amendment Details Statement Value Set | trial-use | 1 | cds | 2026-10 | uv | hl7 | ncit | 2 |
| hl7.fhir.us.pco | R4 | ValueSet-goal-barrier-codes.json | Goal Barrier Assessment Codes | trial-use | 2 | pc | 2026-04 | us | hl7 | sct | 1 |
| hl7.fhir.us.pco | R4 | ValueSet-readiness-assessment-codes.json | Readiness Assessment Codes | trial-use | 2 | pc | 2026-04 | us | hl7 | fhir | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-spl-pharmaceutical-dosage-form-terminology.json | Pharmaceutical Dosage Form Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-spl-drug-route-of-administration-terminology.json | Drug Route Of Administration Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-name-part-terminology.json | PQCMC Name Part Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | tho | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-batch-utilization-terminology.json | Batch utilization Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-chemical-structure-datafile-type-terminology.json | Chemical Structure Data File Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-closure-type-terminology.json | Closure Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-container-type-terminology.json | Container Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-drug-product-component-function-category-terminology.json | Drug Product Component Function Category Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-excipient-function-terminology.json | Excipient Function Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-impurity-classification-terminology.json | Impurity Classification Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-quality-benchmark-terminology.json | Quality Benchmark Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-source-type-terminology.json | Source Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-specification-status-terminology.json | Specification Status Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-specification-type-terminology.json | Specification Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-strength-type-terminology.json | Strength Type Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-test-category-terminology.json | Test Category Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-test-method-origin-terminology.json | Test Method Origin Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-test-usage-terminology.json | Test Usage Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-manufactured-dose-form-terminology.json | Manufactured Dose Form Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-units-of-measure.json | Units Of Measure | trial-use | 2 | brr | 2025-07 | us | hl7 | ucum | 5 |
| kvdigital.terminsynchronisation-tvs | R4 | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Slot_Type.json | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Slot_Type | active | hl7 | tho | 1 | ||||
| kvdigital.terminschnittstelle-fuer-dritte | R4 | KBV_VS_KV_DIGITAL_TS_DRITTE_Appointment_Type.json | KBV_VS_KV_DIGITAL_TS_DRITTE_Appointment_Type | active | tho | 4 | |||||
| ufp.core | R4 | all-languages.json | all-languages | draft | 2017-10 | ietf | |||||
| ans.fr.nos | R4 | ValueSet-JDV-J249-TerritoireSante-ROR.json | JDV_J249-TerritoireSante-ROR | active | 2023-03 | fr | national | 1 | |||
| openehr.base | R5 | ValueSet-territories.json | Territories | informative | 3 | fhir | 2024-08 | uv | hl7 | iso | |
| fhir.nwgenomics.nhs.uk | R4 | ValueSet-GenomicTestOutcomeCodes.json | Genomic Test Outcome Codes | draft | 2026-10 | us | hl7 | internal | 1 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.8004.json | Test Results (Brucellosis) | active | 2020-01 | us | sct tho | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7976.json | Test Titer Type (Brucellosis) | active | 2020-01 | us | sct tho | ||||
| agha.fhir.genclipr | R4 | ValueSet-TestInterpretationValues.json | Test Interpretation Value Set | active | 2022-03 | sct | 1 | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7623.json | Test Method (FDD) | active | 2020-01 | us | tho oid | ||||
| hl7.terminology | R5 | ValueSet-v3-tst0280.json | _0280 | active | 2014-03 | uv | hl7 | tho | 1 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7917.json | CPO PCR method (ARLN) | active | 2019-01 | us | sct oid | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7918.json | CPO AST method (ARLN) | active | 2019-01 | us | sct oid | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7916.json | CPO phenotypic method (ARLN) | active | 2019-01 | us | sct oid | ||||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1032.319.json | Steward Transfer Test | active | 2024-07 | us | hl7 | rx | |||
| ca.on.oh-olis | R4 | vs-TestRequestCodes.json | TestRequestCodes | active | hl7 | 1 | |||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7626.json | Test Result (FDD) | active | 2018-01 | us | sct tho oid | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.8039.json | Test Results (Leptospirosis) | active | 2021-01 | us | sct tho | ||||
| hl7.eu.fhir.idea4rc | R4 | ValueSet-simpleResult-eu-i4rc.json | Simple measures | active | 2026-09 | eu | hl7 | 1 | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7625.json | Test Type (FDD) | active | 2020-01 | us | tho oid | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet-TestUitslagStatusCodelijst-2.16.840.1.113883.2.4.3.11.60.40.2.13.1.15--20200901000000.json | TestUitslagStatusCodelijst | active | nl | hl7 | oid | 1 | |||
| hl7.terminology | R5 | ValueSet-v3-tst0272.json | _0272 | active | 2014-03 | uv | hl7 | tho | 1 | ||
| nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet-TestmethodeCodelijst-2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20200901000000.json | TestmethodeCodelijst | active | nl | hl7 | sct | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-spezifische-bestimmung-tests-loinc.json | MII VS Mikrobio Spezifische Bestimmung Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-resistenzmechanismen-determinanten-loinc.json | MII VS Mikrobio Resistenzmechanismen Determinanten [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-virulenz-loinc.json | MII VS Mikrobio Virulenz [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-ct-wert-loinc.json | MII VS Mikrobio CT Wert [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-aviditaet-tests-loinc.json | MII VS Mikrobio Aviditaet Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-keimzahl-loinc.json | MII VS Mikrobio Keimzahl [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-titer-tests-loinc.json | MII VS Mikrobio Titer Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-allgemeine-bestimmung-tests-loinc.json | MII VS Mikrobio Allgemeine Bestimmung Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-allgemeine-kultur-tests-loinc.json | MII VS Mikrobio Allgemeine Kultur Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-allgemeine-mikroskopie-tests-loinc.json | MII VS Mikrobio Allgemeine Mikroskopie Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-molekulare-pathogenlast-tests-loinc.json | MII VS Mikrobio Molekulare Pathogenlast Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-empfindlichkeit-phenotyp-loinc.json | MII VS Mikrobio Empfindlichkeit Phenotyp [LOINC] | active | 2023-03 | de | loinc | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-spezifische-mikroskopie-tests-loinc.json | MII VS Mikrobio Spezifische Mikroskopie Tests [LOINC] | active | de | loinc | 1 | ||||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-empfindlichkeit-genotyp-loinc.json | MII VS Mikrobio Empfänglichkeit Genotyp [LOINC] | active | 2023-03 | de | loinc | 1 | |||
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie | R4 | ValueSet-mii-vs-mikrobio-antigen-antikoerper-quantitative-tests-loinc.json | MII VS Mikrobio Antigen Antikoerper Quantitative Tests [LOINC] | active | de | loinc | 1 | ||||
| hl7.fhir.be.nihdi-terminology | R4 | ValueSet-be-vs-speech-therapy-pathology-situation-code.json | Speech Therapy Pathology Situation Code | trial-use | fhir | 2026-04 | be | hl7 | internal | 1 | |
| silth.fhir.terminology.core | R5 | ValueSet-th-tmlt.json | TH: รหัส TMLT | active | 2023-10 | internal | 3 | ||||
| silth.fhir.terminology.core | R5 | ValueSet-th-tmt.json | TH: รหัส TMT | active | 2023-10 | internal | 6 | ||||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-bru-org.json | CH ELM Results Bru Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-camp-org.json | CH ELM Results Camp Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-chol-org.json | CH ELM Results Chol Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-cjd-org.json | CH ELM Results Cjd Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-complete-spec.json | CH ELM Results Complete Spec | active | 2026-08 | ch | hl7 | sct | 2 | ||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-diph-org.json | CH ELM Results Diph Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-component-gene-cpe.json | CH ELM Results Gene Cpe | active | 2026-08 | ch | hl7 | loinc | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-component-gene-tb.json | CH ELM Results Gene Tb | active | 2026-08 | ch | hl7 | loinc | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-geni-spec.json | CH ELM Results Geni Spec | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-component-hiv-recency.json | CH ELM Results HIV Recency | active | 2026-08 | ch | hl7 | sct | 1 | ||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-haem-org.json | CH ELM Results Haem Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-hanta-org.json | CH ELM Results Hanta Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-influenza-hxny-org.json | CH ELM Results Influenza Hxny Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-leg-org.json | CH ELM Results Leg Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-lis-org.json | CH ELM Results Lis Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-lis-spec.json | CH ELM Results Lis Spec | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-mal-org.json | CH ELM Results Mal Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-maldi-tof-org.json | CH ELM Results Maldi-tof Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-mea-org.json | CH ELM Results Mea Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-men-org.json | CH ELM Results Men Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-mpox-org.json | CH ELM Results Mpox Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-pneu-org.json | CH ELM Results Pneu Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-sal-org-complete.json | CH ELM Results Sal Org Complete | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-sal-org.json | CH ELM Results Sal Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-shi-nent-org.json | CH ELM Results Shi Nent Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-shi-org.json | CH ELM Results Shi Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-sterile-spec.json | CH ELM Results Sterile Spec | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-tub-org.json | CH ELM Results Tub Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-tul-org.json | CH ELM Results Tul Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-virus-cult-org.json | CH ELM Results Virus Cult Org | active | 2026-08 | ch | hl7 | sct | |||
| ch.fhir.ig.ch-elm | R4 | ValueSet-ch-elm-results-component-antibiotic-tb.json | CH ELM Results Antibiotic Tb | active | 2026-08 | ch | hl7 | loinc | |||
| hl7.terminology | R5 | ValueSet-v3-RoleClassSame.json | RoleClassSame | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-RoleStatusNormal.json | RoleStatusNormal | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ManagedParticipationStatusNormal.json | ManagedParticipationStatusNormal | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-EntityStatusNormal.json | EntityStatusNormal | active | 2014-03 | uv | hl7 | tho | |||
| nostalgic-ie.fhir.core | R4 | ValueSet-ie-core-county.json | Ireland Counties | draft | internal | 4 | |||||
| signal.core.r4 | R4 | valueset-questionnaire-ccars-mental-health-services-program.json | Questionnaire CCARS Mental Health Services Program | draft | 1 | pa | us | hl7 | |||
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-genc-and-iso-intersect.json | GENC and ISO 3166 Intersection | trial-use | 2 | brr | 2025-07 | us | hl7 | fhir | 2 |
| fhir.nwgenomics.nhs.uk | R4 | ValueSet-GMSWGSGuideHPOTermsVS.json | GMS WGS Rare Disease Form - Guide HPO Terms | draft | 2026-10 | us | hl7 | ||||
| hl7.fhir.au.base | R4 | ValueSet-amt-mp-codes.json | AMT Medicinal Product and Substances | deprecated | 3 | 2026-07 | au | hl7 | sct | ||
| hl7.fhir.au.base | R4 | ValueSet-rsg-source-document-type.json | AU Recorded Sex or Gender (RSG) Source Document Type | trial-use | 1 | 2026-07 | au | hl7 | tho loinc | ||
| hl7.fhir.au.base | R4 | ValueSet-rsg-source.json | AU Recorded Sex or Gender (RSG) Source | trial-use | 1 | 2026-07 | au | hl7 | tho | ||
| hl7.fhir.au.base | R4 | ValueSet-rsg-type.json | AU Recorded Sex or Gender Type | trial-use | 1 | 2026-07 | au | hl7 | sct tho loinc | ||
| csiro.fhir.au.smartforms | R4 | ValueSet-AboriginalTorresStraitIslander.json | Aboriginal and/or Torres Strait Islander | draft | 2026-10 | au | hl7 | 1 | |||
| hl7.terminology | R5 | ValueSet-v3-ActStatusActive.json | ActStatusActive | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ActStatusCancelled.json | ActStatusCancelled | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ActStatusAborted.json | ActStatusAborted | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.us.carin-bb | R4 | ValueSet-ADAUniversalNumberingSystem.json | American Dental Association Universal Numbering Value Set | trial-use | 2 | fm | 2026-09 | us | hl7 | tho | 1 |
| silfhirprofileig | R5 | ValueSet-asa-physical-status.json | SGHI ASA Physical Status | active | 2026-10 | internal | |||||
| fhir.argonaut.clinicalnotes | R3 | ValueSet-diagnosticreport-category.json | Argonaut DiagnosticReport Category Value Set | draft | 2018-05 | us | hl7 | loinc | 1 | ||
| fhir.argonaut.clinicalnotes | R3 | ValueSet-documentreference-category.json | Argonaut DocumentReferences Category Value Set | draft | 2018-05 | us | hl7 | internal | 1 | ||
| fhir.argonaut.clinicalnotes | R3 | ValueSet-argonaut-clinical-note-type.json | Argonaut DocumentReferences Type Value Set | draft | 2018-05 | us | hl7 | loinc | |||
| fhir.argonaut.scheduling | R3 | ValueSet-visit-type.json | Argonaut Visit Types | active | 2017-07 | us | hl7 | 4 | |||
| hl7.fhir.au.pd | R4 | ValueSet-endpoint-payload-type.json | Australian Endpoint Payload Types | draft | 0 | 2026-09 | au | hl7 | 2 | ||
| csiro.fhir.au.smartforms | R4 | ValueSet-amt-vaccine-1.json | Australian Medicines Terminology Vaccine | active | 2020-05 | au | hl7 | sct | 2 | ||
| csiro.fhir.au.smartforms | R4 | ValueSet-australian-pronouns-1.json | Australian Pronouns | active | 2024-02 | au | hl7 | tho loinc | |||
| hl7.fhir.au.pd | R4 | ValueSet-service-interfaces.json | Australian Service Interfaces | draft | 0 | 2026-09 | au | hl7 | tho | 2 | |
| hl7.fhir.au.pd | R4 | ValueSet-au-physical-states-territories.json | Australian States and Territories | draft | 0 | 2026-09 | au | hl7 | 2 | ||
| csiro.fhir.au.smartforms | R4 | ValueSet-australian-states-territories-2.json | Australian States and Territories | active | 2020-05 | au | hl7 | 3 | |||
| hl7.eu.fhir.protect-child | R4 | ValueSet-banff-lesion-vs.json | Banff Lesion Score ValueSet | draft | 2026-09 | eu | hl7 | internal | 1 | ||
| fhir.ph.core | R4 | ValueSet-barangays.json | Barangays | draft | 2026-10 | us | hl7 | 2 | |||
| csiro.fhir.au.smartforms | R4 | ValueSet-biological-sex-1.json | Biological Sex | active | 2024-11 | au | hl7 | sct tho | 1 | ||
| hl7.fhir.us.dapl | R4 | ValueSet-dapl-sex-codes.json | DAPL Sex Codes | trial-use | 2 | cgp | 2026-03 | us | hl7 | tho | 1 |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.826.json | Manufacturers of vaccines (MVX) | active | 2022-01 | us | tho | ||||
| cms.fhir.qmd | R4 | ValueSet-cms-measure-scoring.json | CMS Measure Scoring | active | 2026-10 | uv | tho | 1 | |||
| csiro.fhir.au.smartforms | R4 | ValueSet-CVDRiskCategory-1.json | CVD Risk Category | draft | 2026-10 | au | hl7 | sct | |||
| csiro.fhir.au.smartforms | R4 | ValueSet-CVDRiskSmokingStatus-1.json | CVD Risk Smoking Status | draft | 2026-10 | au | hl7 | sct | |||
| ca.on.oh.erec | R4 | CanadianClinicalDrugDataSet-CCDD.json | Canadian Clinical Drug Data Set-CCDD | active | 2022-03 | tho | 4 | ||||
| ca.on.oh-dhdr | R4 | EncounterPriority.json | Encounter Priority | active | us | hl7 | 3 | ||||
| csiro.fhir.au.smartforms | R4 | ValueSet-CervicalScreeningStatus-1.json | Cervical Screening Status | draft | 2026-10 | au | hl7 | sct | |||
| csiro.fhir.au.smartforms | R4 | ValueSet-clinical-condition-1.json | Clinical Condition | active | 2020-05 | au | hl7 | sct | 2 | ||
| hl7.terminology | R5 | ValueSet-v3-ActClassConsent.json | ActClassConsent | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.us.darts | R4 | ValueSet-darts-policy-identifier-codes.json | DARTS Policy Identifer Codes | trial-use | 2 | cgp | 2026-03 | us | hl7 | fhir | |
| hl7.eu.fhir.protect-child | R4 | ValueSet-imm-pat-pk-type-vs.json | Immunosuppressant PK Observation Type ValueSet | draft | 2026-09 | eu | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-dssplus.json | NKRS - DSSplus | active | 2022-02 | ch | hl7 | internal | 1 | ||
| hl7.fhir.us.davinci-atr | R4 | ValueSet-atr-changetype.json | DaVinci ATR Change Types | trial-use | 2 | fm | 2020-09 | us | hl7 | fhir | 2 |
| hl7.fhir.us.davinci-atr | R4 | ValueSet-atr-attribution-list-status.json | DaVinci Attribution List Status | trial-use | 2 | fm | 2020-09 | us | hl7 | fhir | 2 |
| hl7.fhir.us.davinci-atr | R4 | ValueSet-davinci-group-characteristic.json | DaVinci Group Characteristic | trial-use | 2 | fm | 2020-09 | us | hl7 | fhir | 1 |
| ndhm.in | R4 | ValueSet-ndhm-diagnostic-report-type.json | Diagnostic Report Type | draft | 2020-08 | in | national | sct | 3 | ||
| hl7.fhir.us.carin-bb | R4 | ValueSet-FDANationalDrugCode.json | National Drug Code (NDC) Value Set | trial-use | 2 | fm | 2026-09 | us | hl7 | ndc | 1 |
| hl7.fhir.us.davinci-pdex | R4 | ValueSet-FDANationalDrugCode.json | FDA National Drug Code (NDC) | informative | fm | 2026-08 | us | hl7 | ndc | 1 | |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7776.json | Emergency Severity Index - Acuity | active | 2018-01 | us | oid | ||||
| hl7.fhir.us.davinci-pct | R4 | ValueSet-PCTGFEItemNDCVS.json | PCT GFE Item NDC Value Set | trial-use | 2 | fm | 2026-03 | us | hl7 | ndc | 1 |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.6039.json | Funding Eligibility Observation Method (IIS) | active | 2012-01 | us | oid | ||||
| csiro.fhir.au.smartforms | R4 | ValueSet-gender-identity-response-1.json | Gender Identity Response | active | 2024-02 | au | hl7 | sct tho | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.113883.3.88.12.80.64.json | Medication Fill Status Value Set | active | 2009-01 | us | tho | ||||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.4.642.2.575.json | Race Categories | active | 2025-04 | us | hl7 | vsac | 2 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.4.642.40.2.48.3.json | Ethnicity Categories | active | 2025-04 | us | hl7 | vsac | 2 | ||
| hl7.fhir.us.vitals | R4 | ValueSet-NumericResultIntNonPanicVS.json | Numeric Result Interpretation without panic values, value set | draft | 2024-10 | us | hl7 | tho | 5 | ||
| lt.hl7.fhir.vitalsigns | R5 | ValueSet-numeric-result-interpretation-non-panic.json | Numeric Result Interpretation without panic values, value set | active | 2025-11 | tho | 5 | ||||
| hl7.fhir.us.vitals | R4 | ValueSet-NumericResultIntVS.json | Numeric Result Interpretation value set | draft | 2024-10 | us | hl7 | tho | 4 | ||
| hl7.fhir.us.cardx-htn | R4 | ValueSet-NumericResultIntVS.json | Numeric Result Interpretation value set | draft | 2023-08 | us | hl7 | tho | 4 | ||
| hl7.fhir.uv.cardx-htn-mng | R4 | ValueSet-NumericResultIntVS.json | Numeric Result Interpretation value set | draft | cic | 2024-12 | uv | hl7 | tho | ||
| lt.hl7.fhir.vitalsigns | R5 | ValueSet-numeric-result-interpretation.json | Numeric Result Interpretation value set | active | 2025-11 | tho | 2 | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.113883.3.88.12.3221.3.2.json | Contact Type Value Set | active | 2009-01 | us | tho | ||||
| hl7.terminology | R5 | ValueSet-v3-HL7FormatCodes.json | HL7 ValueSet of Format Codes for use with Document Sharing | active | 2024-02 | uv | hl7 | ihe tho | 3 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.1066.json | Healthcare Provider Taxonomy (HIPAA) | active | 2008-01 | us | tho | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.113883.11.19465.json | Healthcare Provider Taxonomy Code (NUCC) | active | 2019-01 | us | nucc | ||||
| csiro.fhir.au.smartforms | R4 | ValueSet-heart-rhythm-1.json | Heart Rhythm | draft | 2026-10 | au | hl7 | sct | 1 | ||
| uz.dhp.integrations | R5 | ValueSet-dmed-ichi-vs.json | ICHI Codes Accepted by DMED | active | 2026-09 | 1 | |||||
| ihe.formatcode.fhir | R4 | ValueSet-formatcode.json | IHE ValueSet of Format Codes for use with Document Sharing | active | 2022-08 | uv | ihe | ihe tho ietf | 2 | ||
| hl7.fhir.us.covid19library | R4 | ValueSet-iso-state-codes-value-set.json | ISO Code System 3166 state/province codes. | active | 2022-07 | us | hl7 | iso | 1 | ||
| hl7.fhir.us.covid19library | R4 | ValueSet-iso-country-codes-value-set.json | ISO Code System 3166 country codes | active | 2022-07 | us | hl7 | iso | 1 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7900.json | Industry NAICS Detail (ODH) | active | 2020-01 | us | tho | 4 | |||
| hl7.fhir.uv.cqm | R4 | ValueSet-intended-venue.json | Intended Venue | trial-use | 4 | cqi | 2026-09 | uv | hl7 | fhir | 2 |
| hl7.fhir.us.cqfmeasures | R4 | ValueSet-intended-venue.json | Intended Venue | active | cqi | 2025-08 | us | hl7 | fhir | 1 | |
| us.cdc.phinvads | R4 | ValueSet-1.3.6.1.4.1.33895.1.3.0.75.json | Joint Commission Medical Reason | active | 2010-01 | us | sct | ||||
| hl7.terminology | R5 | ValueSet-v3-LoincDocumentOntologyInternational.json | LoincDocumentOntologyInternational | active | 2014-03 | uv | hl7 | loinc | |||
| hl7.terminology | R5 | ValueSet-v3-LogicalObservationIdentifierNamesAndCodes.json | LogicalObservationIdentifierNamesAndCodes | active | 2014-03 | uv | hl7 | loinc | 2 | ||
| nl.generiekefuncties.csd | R4 | ValueSet-nl-gf-location-type-vs.json | NL GF Location Types ValueSet | active | 2026-10 | nl | tho | 1 | |||
| hl7.fhir.au.base | R4 | ValueSet-mims.json | MIMS | trial-use | 2 | 2026-07 | au | hl7 | 5 | ||
| csiro.fhir.au.smartforms | R4 | ValueSet-medication-reason-taken-1.json | Medication Reason Taken | active | 2020-07 | au | hl7 | sct | 1 | ||
| hl7.fhir.au.base | R4 | ValueSet-medication-type.json | Medication Type | trial-use | 2 | 2026-07 | au | hl7 | tho | 1 | |
| hl7.fhir.au.base | R4 | ValueSet-medicine-item-change.json | Medicine Item Change | trial-use | 1 | 2026-07 | au | hl7 | tho | 1 | |
| hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet-codexrt-radiotherapy-adverse-event-termVS.json | Adverse Event Terms Value Set | trial-use | cgp | 2026-05 | us | hl7 | ncit tho | 1 | |
| hl7.fhir.au.base | R4 | ValueSet-name-context.json | Name Context | trial-use | 1 | 2026-07 | au | hl7 | tho | 1 | |
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-NIHSS10Dysartri.json | NIHSS - 10. Dysartri | active | 2022-06 | internal | |||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-NIHSS11EkstinktionInattention.json | NIHSS - 11. Ekstinktion og inattention | active | 2022-06 | internal | |||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-NIHSS1aBevidsthedsniveau.json | NIHSS - 1a. Bevidsthedsniveau | active | 2022-06 | internal | |||||
| dk.kip.rkkp.fhir.ig.core | R4 | ValueSet-NIHSS1bBevidsthedsniveau.json | NIHSS - 1b. Bevidsthedsniveau: spørgsmål | active | 2022-06 | internal |
FHIR
FHIRsmith